`Patent 8,404,703 B2
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`PANACEA BIOTEC LTD.,
`Petitioner
`
`v.
`
`DAIICHI SANKYO CO., LTD. and UBE INDUSTRIES, LTD.,
`Patent Owners.
`__________________
`
`Case IPR2015-01496
`Patent 8,404,703 B2
`__________________
`
`
`
`PATENT OWNERS’ MANDATORY NOTICES
`
`37 C.F.R. § 42.8(a)(2)
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(2), the Patent Owners submit the following
`
`Case IPR2015-01496
`Patent 8,404,703 B2
`
`
`
`
`mandatory notices:
`
`
`
`(1) Real parties-in-interest.
`
`Daiichi Sankyo Co., Ltd. is a corporation organized and existing under the
`
`laws of Japan and has a principal place of business at 3-5-1, Nihonbashi-honcho,
`
`Chuo-ku, Tokyo 103-8426, Japan. Daiichi Sankyo Co., Ltd. is an assignee of U.S.
`
`Patent No. 8,404,703 (“the ’703 patent”).
`
`Daiichi Sankyo, Inc. is a corporation organized and existing under the laws
`
`of the State of Delaware and has a principal place of business at Two Hilton Court,
`
`Parsippany, New Jersey 07054. Daiichi Sankyo, Inc. is a wholly-owned subsidiary
`
`of Daiichi Sankyo U.S. Holdings, Inc., which is a corporation organized and
`
`existing under the laws of the State of Delaware and has a principal place of
`
`business at Two Hilton Court, Parsippany, New Jersey 07054. Daiichi Sankyo
`
`U.S. Holdings, Inc. is a wholly-owned subsidiary of Daiichi Sankyo Co., Ltd.
`
`Ube Industries, Ltd. is a corporation organized and existing under the laws
`
`of Japan and has a principal place of business at 1978-96, Kogushi, Ube,
`
`Yamaguchi 755-8633, Japan. Ube Industries, Ltd. is an assignee of the ’703
`
`patent.
`
`Eli Lilly and Company, a publicly traded company, is a corporation
`
`organized and existing under the laws of the State of Indiana and has a principal
`
`
`
`
`
`
`place of business at Lilly Corporate Center, Indianapolis, Indiana 46285. Eli Lilly
`
`Case IPR2015-01496
`Patent 8,404,703 B2
`
`and Company is an exclusive licensee of the ’703 patent.
`
`(2) Related matters.
`
`The following matters, in which the ’703 patent has been asserted, could
`
`affect, or be affected by, a decision in this proceeding:
`
`• Eli Lilly and Co., Daiichi Sankyo Co., Ltd., Daiichi Sankyo, Inc., &
`Ube Industries, Ltd. v. Accord Healthcare Inc., USA, Accord
`Healthcare, Inc., Intas Pharmaceuticals Ltd., Amneal
`Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC,
`Amneal Pharmaceuticals Co. India Pvt. Ltd., Aurobindo Pharma Ltd.,
`Aurobindo Pharma USA Inc., Dr. Reddy’s Laboratories, Ltd., Dr.
`Reddy’s Laboratories, Inc., Glenmark Generics Inc., USA, Glenmark
`Generics Ltd., Glenmark Pharmaceuticals Ltd., Hetero USA Inc.,
`Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero Drugs Ltd., Mylan
`Pharmaceuticals Inc., Mylan Inc., Mylan Laboratories Ltd., Sun
`Pharma Global FZE, Teva Pharmaceuticals USA, Inc., Watson
`Laboratories, Inc., Zydus Pharmaceuticals USA, Inc., Cadila
`Healthcare Ltd. (d/b/a Zydus Cadila), No. 1:14-cv-00389-SEB-TAB
`(S.D. Ind.)
`
`• Eli Lilly and Co., Daiichi Sankyo Co., Ltd., Daiichi Sankyo, Inc., &
`Ube Industries, Ltd. v. Apotex Corp & Apotex Inc., No. 1:14-cv-
`00586-SEB-TAB (S.D. Ind.)
`
`• Eli Lilly and Co., Daiichi Sankyo Co., Ltd., Daiichi Sankyo, Inc., &
`Ube Industries, Ltd. v. Panacea Biotec, Ltd., No. 1:14-cv-01064-SEB-
`TAB (S.D. Ind.)
`
`• Eli Lilly and Co., Daiichi Sankyo Co., Ltd., Daiichi Sankyo, Inc., &
`Ube Industries, Ltd. v. First Time US Generics LLC, No. 1:14-cv-
`01168-SEB-TAB (S.D. Ind.)
`
`
`
`
`
`
`
`
`
`2
`
`
`
`
`The above-listed matters have been consolidated under Civil Action No. 1:14-cv-
`
`Case IPR2015-01496
`Patent 8,404,703 B2
`
`00389-SEB-TAB, which is currently pending in the U.S. District Court for the
`
`Southern District of Indiana.
`
`Additional matters in which the ’703 patent has been asserted, could affect,
`
`or be affected by, a decision in this proceeding, and which have not been
`
`consolidated with Civil Action No. 1:14-cv-00389-SEB-TAB (S.D. Ind.), are listed
`
`below:
`
`• Eli Lilly and Co., Daiichi Sankyo Co., Ltd., Daiichi Sankyo, Inc., & Ube
`
`Industries, Ltd. v. Lupin Ltd. and Lupin Pharmaceuticals, Inc., No. 1:15-cv-
`
`00673-SEB-TAB (S.D. Ind.)
`
`• Eli Lilly and Co., Daiichi Sankyo Co., Ltd., Daiichi Sankyo, Inc., & Ube
`
`Industries, Ltd. v. HEC Pharm USA, Inc. and HEC Pharm Co. Ltd., No.
`
`1:15-cv-00792-SEB-TAB (S.D. Ind.)
`
`The petitioner, along with other petitioning parties, has a pending petition
`
`for inter partes review of this same patent in Case IPR2015-00864.
`
`The petitioner has also filed a petition for inter partes review of U.S. Patent
`
`No. 8,569,325 (“the ’325 patent”), which claims priority to the same applications
`
`as the ’703 patent. That proceeding is Case IPR2015-01492. The petitioner, along
`
`with other petitioning parties, also has a pending petition for inter partes review of
`
`’325 patent in Case IPR2015-00865.
`
`
`
`3
`
`
`
`(3) Lead and back-up counsel.
`
`Case IPR2015-01496
`Patent 8,404,703 B2
`
`
`
`
`
`The Patent Owners designate the following lead and back-up counsel:
`
`
`
`Lead Counsel:
`
`Dov P. Grossman
`
`Reg. No. 72,525
`
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5812 (Telephone)
`202-434-5029 (Facsimile)
`dgrossman@wc.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Back-up Counsel:
`Andrew V. Trask
`Reg. No. 59,239
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5098 (Telephone)
`202-434-5029 (Facsimile)
`atrask@wc.com
`
`
`
`
`
`
`
`Powers of attorney appointing these attorneys to transact all business in this
`
`proceeding are submitted together with this mandatory notice information.
`
`(4) Service information.
`
`Counsel for Patent Owners submits the following service information:
`
`(i)
`
`Electronic mail address:
`
`
`(ii) Postal mailing address:
`
`dgrossman@wc.com
`atrask@wc.com
`Effient-IPR@wc.com
`
`Dov P. Grossman
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington D.C. 20005
`
`(iii) Hand-delivery address: Dov P. Grossman
`Williams & Connolly LLP
` 725 Twelfth Street, N.W.
` Washington D.C. 20005
`
`
`
`4
`
`
`
`
`
`
`
`(iv) Telephone number:
`
`Facsimile number:
`
`(v)
`
`
`
`
`
`202-434-5812
`
`202-434-5029
`
`Case IPR2015-01496
`Patent 8,404,703 B2
`
`
`
`
`
`Counsel for Patent Owners consent to electronic service by email at
`dgrossman@wc.com, atrask@wc.com, and Effient-IPR@wc.com.
`
`Dated: July 17, 2015
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dov P. Grossman/
`Dov P. Grossman
`Reg. No. 72,525
`Lead Counsel for
`Patent Owners
`
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5812 (Telephone)
`202-434-5029 (Facsimile)
`dgrossman@wc.com
`
`
`
`
`
`5
`
`
`
`Case IPR2015-01496
`Patent 8,404,703 B2
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing Patent Owners’
`
`Mandatory Notices were served on July 17, 2015 through the Patent Review
`Processing System as well as by delivering a copy via electronic mail on the
`following attorneys of record for the Petitioner:
`
`Samuel S. Park (Reg. #59,656)
`Email: spark@winston.com
`Prasugrel-IPR@winston.com
`WINSTON & STRAWN LLP
`35 W. Wacker Drive
`Chicago, IL 60601
`Telephone: (312) 558-7931
`Fax: (312) 558-5700
`
`Andrew R. Sommer (Reg. # 53,932)
`Email: asommer@winston.com
`WINSTON & STRAWN LLP
`1700 K. Street NW
`Washington, D.C. 20006
`Telephone: (202) 558-5000
`Fax: (202) 282-5100
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dov P. Grossman/
`Dov P. Grossman
`Reg. No. 72,525
`Lead Counsel for
`Patent Owners
`
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5812 (Telephone)
`202-434-5029 (Facsimile)
`dgrossman@wc.com
`
`
`Dated: July 17, 2015